User talk:LexRob

Hi all, my first edit. Hopefully I haven't messed up.

Existing Text:

The U.S. government classification of marijuana as a Schedule I drug (having no accepted medical use) is contradicted by several scientific studies which suggest that it may in fact have medicinal value as a treatment for ailments such as cancer,[6] glaucoma, Fibromyalgia,[7] and neuropathic pain,[8] among others.

My addition as a continuation of the paragraph:

In fact, in the abstract for patent number 6630507[9] filed Feb. 2, 2001 "Cannabinoids as antioxidants and neuroprotectants", held by the United States of America as represented by the Department of Health and Human Services (Washington, DC), they state "Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia."

The quote has been copied from the US Patent and Trademark website which I believe to be in the public domain and therefore hopefully acceptable. LexRob (talk) 23:27, 9 October 2008 (UTC)